Joint Pain Blood Test UK: The Biomarkers That Distinguish Inflammatory Arthritis, Gout & Autoimmune Disease from Wear-and-Tear

1. hs-CRP (High-Sensitivity C-Reactive Protein)

CRP is a liver-produced acute-phase protein that rises within hours of tissue injury or inflammation. The high-sensitivity version detects levels below the threshold of standard CRP assays. In joint pain, a raised hs-CRP confirms systemic inflammation is present — it does not identify the cause, but it immediately distinguishes inflammatory from non-inflammatory disease. In active rheumatoid arthritis, CRP is elevated in around 80% of cases and tracks disease activity closely.

A CRP that is persistently elevated despite treatment is a signal of inadequate disease control and is used by rheumatologists to guide DMARD dose escalation. The British Society for Rheumatology (BSR) includes CRP as a standard monitoring marker for all inflammatory arthropathies.

2. ESR (Erythrocyte Sedimentation Rate)

ESR measures how quickly red blood cells settle in a tube of blood — they settle faster when inflammatory proteins (fibrinogen, immunoglobulins) are elevated. ESR rises more slowly than CRP and falls more slowly, making it a better marker of chronic, sustained inflammation rather than acute flares. In conditions like polymyalgia rheumatica (PMR) and giant cell arteritis, ESR is often dramatically elevated (above 40–100 mm/hr).

The combination of raised ESR and raised CRP is more diagnostically powerful than either alone. ESR also rises with age and anaemia, so results must be interpreted in context. A normal ESR does not exclude inflammatory joint disease, particularly early RA where it may be normal in the first few months.

3. Full Blood Count (FBC)

The FBC provides multiple relevant signals in joint disease. Anaemia of chronic disease (normocytic, normochromic anaemia with low serum iron but adequate ferritin) is present in up to 60% of patients with active RA and reflects the immune suppression of red cell production. Thrombocytosis (elevated platelets) occurs as an acute-phase response in active inflammation and correlates with disease activity. Leucocytosis may suggest infection triggering reactive arthritis.

The NHS includes FBC as a standard investigation for suspected inflammatory joint disease, and it provides baseline values before starting DMARDs such as methotrexate, which require regular haematological monitoring.

4. Uric Acid (Serum Urate)

Gout occurs when monosodium urate crystals deposit in joints and periarticular tissues, causing intense inflammation. Serum urate above 360 μmol/L (6 mg/dL) is the threshold above which urate is supersaturated in plasma and crystal deposition becomes more likely. NICE NG226 recommends checking serum urate in all suspected gout cases.

Critically, urate can be normal or even low during an acute gout attack, as crystals drawn from the blood into the joint transiently reduce circulating levels. A normal urate during a flare does not exclude gout. Testing four to six weeks after the acute episode gives a more reliable baseline.

5. Rheumatoid Factor (RF)

RF is an antibody (usually IgM) directed against the Fc portion of IgG. It is present in around 70–80% of people with established RA but is not specific — RF is also elevated in Sjögren's syndrome, hepatitis C, infective endocarditis, and even in around 5% of healthy adults. High-titre RF (above 100 IU/mL) is more likely to be clinically significant than borderline elevations.

A positive RF in the context of joint pain, morning stiffness, and elevated CRP or ESR makes inflammatory arthritis highly likely and warrants urgent rheumatology referral. A negative RF does not exclude RA (seronegative RA is a recognised entity) — if clinical suspicion is high, anti-CCP should be added.

6. Anti-CCP Antibodies (Anti-Cyclic Citrullinated Peptide)

Anti-CCP is the most specific blood test for RA currently available. It detects antibodies directed against citrullinated proteins, a post-translational modification that occurs in inflamed synovial tissue. Specificity for RA exceeds 95%, compared to around 85% for RF. Anti-CCP can be positive years before clinical symptoms develop — making it a potential early detection marker in at-risk individuals.

The combination of positive RF and positive anti-CCP with raised inflammatory markers represents a high-risk seropositive pattern associated with more erosive disease and worse prognosis. NICE NG100 recognises anti-CCP as a recommended investigation in RA assessment.

7. ANA (Antinuclear Antibodies)

ANA testing detects antibodies directed against components of the cell nucleus. A positive ANA (typically at titre 1:160 or above) raises suspicion for systemic autoimmune connective tissue diseases including systemic lupus erythematosus (SLE), Sjögren's syndrome, systemic sclerosis, and mixed connective tissue disease — all of which can cause joint pain as a prominent feature.

ANA is a screening test, not diagnostic. A positive ANA requires further investigation with specific antibodies (anti-dsDNA for SLE, anti-Ro/La for Sjögren's, anti-Scl-70 for systemic sclerosis). Around 15–20% of healthy adults have a low-positive ANA, so clinical context is essential. In a young woman with joint pain, rash, and fatigue, a positive ANA should prompt urgent further evaluation.

8. Vitamin D (25-OH Vitamin D)

Vitamin D deficiency (below 50 nmol/L) is one of the most common and most underrecognised causes of widespread musculoskeletal pain in the UK. It can produce aching, tenderness, and fatigue that closely mimics fibromyalgia, and it worsens inflammatory arthritis by promoting immune dysregulation. Around 1 in 5 adults in the UK has low vitamin D levels.

The NHS recommends supplementation for those at risk. SACN 2016 recommends a population reference intake of 10 μg/day (400 IU), but optimal levels for musculoskeletal health are above 75 nmol/L according to evidence reviewed by NICE NG34. Testing before supplementing allows appropriate dose selection.

9. Ferritin

Ferritin is the body's primary iron storage protein. In the context of joint pain, extremely elevated ferritin (above 1,000 μg/L, particularly in combination with elevated transferrin saturation above 45%) strongly raises suspicion for hereditary haemochromatosis — a condition where excess iron deposits in multiple organs including joint cartilage.

Haemochromatosis arthropathy characteristically affects the metacarpophalangeal (MCP) joints of the second and third fingers, producing a “iron fist” appearance with chondrocalcinosis. Early detection through ferritin testing can prevent further organ damage (liver, heart, pancreas) with treatment as simple as regular phlebotomy. The NHS recognises haemochromatosis as one of the most common inherited conditions in Northern European populations.

10. HbA1c

HbA1c measures average blood glucose over three months. Its relevance to joint pain operates through several mechanisms. Diabetic cheiroarthropathy (stiff hand syndrome) produces thickening of skin and periarticular tissues, reducing finger extension and causing joint contractures. More broadly, hyperglycaemia promotes glycation of collagen, altering the mechanical properties of cartilage and tendons. Metabolic inflammation driven by insulin resistance also elevates CRP independently of other inflammatory processes.

NICE NG226 specifically recommends HbA1c testing in newly diagnosed gout, recognising the high comorbidity between gout and type 2 diabetes. An HbA1c above 48 mmol/mol (6.5%) confirms diabetes; 42–47 mmol/mol (6.0–6.4%) defines pre-diabetes and warrants lifestyle intervention.

1. Rheumatoid Arthritis

RA is a chronic autoimmune condition affecting around 400,000 people in the UK. The characteristic blood test finding is the combination of positive RF, positive anti-CCP, and elevated CRP and ESR — though anti-CCP alone with a consistent clinical picture is sufficient to trigger urgent referral under NICE NG100. FBC often shows anaemia of chronic disease with thrombocytosis.

RA has a window of opportunity: joint damage is most aggressive in the first two years. DMARDs (methotrexate, leflunomide, sulfasalazine) significantly reduce the rate of erosion when started early. Seronegative RA (negative RF and anti-CCP) is diagnosed clinically by a rheumatologist — a negative blood test is not a reason to withhold referral if clinical features are convincing.

2. Gout

Gout affects around 2.5% of adults in the UK and is substantially underdiagnosed and undertreated. NHS guidance describes the classic presentation: sudden-onset severe pain, swelling, and redness, most commonly in the first metatarsophalangeal joint (big toe), though ankles, knees, and wrists are also frequently affected.

Blood tests show elevated serum urate (typically above 420 μmol/L), raised CRP during flares, and normal or negative RF and ANA — which helps distinguish gout from inflammatory arthritis. Importantly, urate can be normal during an acute flare. NICE NG226 recommends urate-lowering therapy (allopurinol or febuxostat) to maintain urate below 360 μmol/L long-term, with the target of below 300 μmol/L for those with tophi or frequent flares.

3. Hereditary Haemochromatosis

Haemochromatosis is caused by mutations in the HFE gene (most commonly C282Y) that lead to excess iron absorption. Around 1 in 200 people of Northern European descent are homozygous for this mutation. Iron accumulates in the liver, heart, pancreas, skin — and joints, causing chondrocalcinosis and arthropathy that clinically resembles osteoarthritis but characteristically affects the second and third MCP joints.

Blood tests show very high ferritin (often above 1,000–3,000 μg/L) and elevated transferrin saturation (above 45%). Liver enzymes are often elevated. The NHS recommends genetic testing once iron overload is confirmed. Treatment with therapeutic phlebotomy (venesection) halts progression and can partially reverse organ damage if started before irreversible fibrosis develops.

4. Vitamin D Deficiency

Vitamin D deficiency is present in an estimated 20% of UK adults and is particularly common in those with darker skin, limited sun exposure, obesity, and inflammatory conditions. It causes diffuse musculoskeletal pain, bone aching, proximal muscle weakness, and fatigue — a constellation that is often attributed to fibromyalgia or depression before a vitamin D level is checked.

The mechanism involves vitamin D's role in calcium absorption and its direct effects on muscle and immune function. Vitamin D receptors are present in synovial tissue, and deficiency promotes pro-inflammatory cytokine production — potentially worsening the inflammatory burden in conditions like RA. Supplementation to above 75 nmol/L is associated with improvements in musculoskeletal pain in multiple studies, reviewed by SACN 2016.

5. Autoimmune Connective Tissue Disease

Systemic lupus erythematosus (SLE), Sjögren's syndrome, systemic sclerosis, and mixed connective tissue disease all commonly cause joint pain as an early feature, often preceding other organ manifestations by months or years. Blood tests show positive ANA (often at high titre), elevated ESR with normal or mildly raised CRP (a pattern characteristic of SLE), low complement (C3, C4), and specific antibodies depending on the condition.

In a young woman with joint pain, hair loss, rash, and fatigue — or a middle-aged woman with dry eyes, dry mouth, and aching joints — an ANA is an essential investigation. A positive result with compatible symptoms warrants urgent rheumatology referral, not watchful waiting.

1. Mediterranean Diet

A Mediterranean dietary pattern — high in olive oil, fish, vegetables, legumes, nuts, and whole grains — reduces systemic inflammatory markers including CRP and IL-6. A BMJ meta-analysis (2018) found significant reductions in CRP and other inflammatory cytokines compared with control diets. For RA specifically, the anti-inflammatory properties of the Mediterranean diet may reduce disease activity and improve pain and functional outcomes as an adjunct to pharmacological treatment.

2. Omega-3 Fatty Acids

Marine omega-3 fatty acids (EPA and DHA) suppress the production of pro-inflammatory eicosanoids and cytokines including TNF-alpha and IL-1beta — the same cytokines targeted by biological DMARDs in RA. A Cochrane systematic review found that fish oil supplementation reduces joint pain intensity, morning stiffness, and the number of tender joints in RA, with a moderate-quality evidence base. Standard supplementation doses range from 2–4 g EPA+DHA per day.

3. Vitamin D Supplementation

Where deficiency is confirmed (below 50 nmol/L), vitamin D supplementation reliably raises levels and can substantially improve musculoskeletal pain in people with deficiency-driven symptoms. The SACN 2016 report recommends 400 IU daily for the general population, with higher doses appropriate for those with confirmed deficiency or increased requirements. Beyond direct pain effects, adequate vitamin D supports immune regulation, which is relevant in autoimmune joint conditions.

4. Weight Management

The mechanical benefit of weight loss on joint load is substantial. NICE CG189 and CG177 both recognise weight management as a first-line treatment for OA, particularly knee OA. Every 1 kg reduction in body weight reduces the compressive force on the knee joint by approximately 4 kg per step. For gout, weight loss also reduces urate production and can lower serum urate significantly without pharmacological intervention. In inflammatory arthritis, adipose tissue is a source of pro-inflammatory adipokines including leptin and resistin, and weight reduction can reduce disease activity independently of mechanical effects.

5. Regular Exercise

Counter-intuitively, exercise is the single most effective intervention for OA. NICE CG177 recommends both aerobic exercise and muscle-strengthening exercises as core treatments. Strengthening the muscles around affected joints reduces joint loading and improves stability. For inflammatory arthritis, moderate aerobic exercise reduces CRP and ESR, improves cardiovascular outcomes (cardiovascular risk is elevated in RA due to chronic inflammation), and does not worsen joint damage. The key is starting gently and building incrementally, ideally with physiotherapist guidance.

6. Reducing Alcohol Intake

Alcohol is the single most modifiable risk factor for gout. NICE NG226 recommends reducing alcohol intake as part of gout management, as alcohol (particularly beer and spirits) both increases urate production and reduces renal urate excretion, raising serum urate. Beer in particular is high in purines. For RA, alcohol can interact with methotrexate (increasing hepatotoxicity risk) and undermines the anti-inflammatory benefits of dietary modification. Reducing alcohol also reduces systemic inflammation as measured by CRP.

What blood tests should I ask my GP for if I have joint pain?

As a minimum, ask for CRP or ESR, a full blood count, uric acid, and rheumatoid factor. If inflammatory arthritis is suspected, add anti-CCP. Ask about vitamin D if you have widespread musculoskeletal pain. If a connective tissue disease is possible (young woman with joint pain, rash, fatigue), request ANA. For joint pain with fatigue and bronze skin, ask about ferritin and transferrin saturation to screen for haemochromatosis.

Can blood tests diagnose rheumatoid arthritis?

Blood tests cannot diagnose RA alone — the diagnosis requires clinical assessment by a rheumatologist. However, positive anti-CCP antibodies with a consistent clinical picture strongly supports the diagnosis. Importantly, a negative RF does not exclude RA — seronegative RA affects around 20–30% of patients and is diagnosed on clinical grounds.

My CRP is normal but my joints are still very painful and stiff in the morning. Could it still be inflammatory?

Yes. A normal CRP does not exclude inflammatory arthritis, particularly early RA, seronegative RA, or psoriatic arthritis. ESR may be elevated when CRP is normal. More importantly, NICE NG100 says referral should be based on clinical features, not purely on blood test results. If you have morning stiffness lasting more than 30 minutes with swollen MCP or PIP joints, ask for an urgent rheumatology referral regardless of your CRP.

My uric acid came back normal but I'm having what seems like gout attacks. Can I still have gout?

Yes. Serum urate can be normal or even low during an acute gout flare, because urate redistributes from blood into the affected joints during the attack. If your presentation is clinically typical of gout (sudden-onset severe pain, redness, and swelling, often in the big toe, ankle, or knee), a normal urate during the flare does not exclude the diagnosis. Test urate four to six weeks after the episode for a reliable baseline measurement.

My ferritin was very high — does that mean I have haemochromatosis?

Not necessarily. Ferritin is an acute-phase reactant and rises with any acute inflammation, infection, liver disease, or alcohol use. The pattern that suggests haemochromatosis is very high ferritin combined with elevated transferrin saturation (above 45%) in the absence of significant inflammation. Your GP should check transferrin saturation and, if this is elevated, request HFE genetic testing.

My ANA came back positive. What does this mean?

A positive ANA is a common finding — around 15–20% of healthy adults have a low-positive ANA at titres of 1:40 or 1:80. At higher titres (1:160 or above), particularly with compatible symptoms (joint pain, fatigue, rash, dry eyes or mouth), a positive ANA warrants further investigation with specific antibodies (anti-dsDNA, anti-Ro/La) and rheumatology referral. A positive ANA alone, without symptoms, is usually not clinically significant.

Will my GP accept private blood test results for a rheumatology referral?

Most GPs will review private blood test results and they can support a referral decision. However, some may wish to repeat a confirmatory test (particularly anti-CCP or ANA) through their own NHS lab before actioning a referral. Present your results clearly, explain your symptoms, and specifically ask about an urgent rheumatology referral under NICE NG100 if you have features of inflammatory arthritis. UKAS-accredited private labs, which Helvy uses, meet the same quality standards as NHS laboratories.